Abstract
Advancing health interoperability can significantly benefit health research, including phenotyping, clinical trial support, and public health surveillance. Federal agencies, including ONC, CDC, and CMS, have been collectively collaborating to promote interoperability by adopting Fast Healthcare Interoperability Resources (FHIR). However, the heterogeneous structures and formats of health data present challenges when transforming Electronic Health Record (EHR) data into FHIR resources. This challenge becomes more significant when critical health information is embedded in unstructured data rather than well-organized structured formats. Previous studies relied on multiple separate rule-based or deep learning-based NLP tools to complete the FHIR resource transformation, which demands substantial development costs, extensive training data, and meticulous integration of multiple individual NLP tools. In this study, we assessed the ability of large language models (LLMs) to transform clinical narratives into HL7 FHIR resources. We developed FHIR-GPT specifically for the transformation of clinical texts into FHIR medication statement resources. In our experiments using 3,671 snippets of clinical texts, FHIR-GPT demonstrated an exceptional exact match rate of over 90%, surpassing the performance of existing methods. FHIR-GPT improved the exact match rates of existing NLP pipelines by 3% for routes, 12% for dose quantities, 35% for reasons, 42% for forms, and over 50% for timing schedules. Our findings provide the foundations for leveraging LLMs to enhance health data interoperability. Future studies will aim to build upon these successes by extending the generation to additional FHIR resources.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was conducted when Yikuan Li is a research intern at Siemens Healthineers.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All datasets are publicly available at https://mimic.mit.edu/docs/iii/ https://portal.dbmi.hms.harvard.edu/projects/n2c2-nlp/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Add two additional experiments on error and reproducibility analysis.
